David A. Spellman

Insider Reports History

Location
Cambridge, MA
Signature
/s/ Carolyn Rucci, attorney-in-fact for David A. Spellman
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by David A. Spellman:

Company Role Class Num Shares Value Price $ Report Date Ownership
Akebia Therapeutics, Inc. SVP, CFO and Treasurer Common Stock 446,483 $546,004 $1.22 16 May 2023 Direct

Insider Reports Filed by David A. Spellman

Symbol Company Period Transactions Value $ Form Type Role Filing Time
AKBA Akebia Therapeutics, Inc. 16 May 2023 1 -$67,890 4 SVP, CFO and Treasurer 18 May 2023, 18:19
AKBA Akebia Therapeutics, Inc. 01 Mar 2023 2 -$6,327 4 SVP, CFO and Treasurer 03 Mar 2023, 07:00
AKBA Akebia Therapeutics, Inc. 27 Feb 2023 1 -$6,131 4 SVP, CFO and Treasurer 01 Mar 2023, 15:05
AKBA Akebia Therapeutics, Inc. 31 Jan 2023 2 $0 4 SVP, CFO and Treasurer 02 Feb 2023, 15:14
AKBA Akebia Therapeutics, Inc. 08 Jun 2022 2 $0 4 SVP, CFO and Treasurer 10 Jun 2022, 08:11
AKBA Akebia Therapeutics, Inc. 28 Feb 2022 4 -$17,689 4 SVP, CFO and Treasurer 02 Mar 2022, 20:09
AKBA Akebia Therapeutics, Inc. 30 Sep 2021 1 $0 4 SVP, CFO and Treasurer 01 Oct 2021, 16:06